 |
glycyl-L-2-methylpropyl-L-glutamic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Rett syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-02-11 00:00:00 |
| Sponsor | Neuren Pharmaceuticals, Ltd.;Level 1, 57 Wellington Street, Auckland 1011; |
| |
glycyl-L-2-methylpropyl-L-glutamic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Rett syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-02-11 00:00:00 |
| Sponsor | Neuren Pharmaceuticals, Ltd.;Level 1, 57 Wellington Street, Auckland 1011; |